author-photo

Valeria Belsito Petrizzi

Seconda Università degli Studi di Napoli

17

Papers

412

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Hematological Toxicity During Concomitant Treatment With Ruxolitinib and Avelumab for Merkel Cell Carcinoma

2020 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (1)
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (65)
Long Term Toxicity and Follow-up of Waldenstrom´s Macroglobulinemia Patients after Salvage Treatment with Fludarabine Cyclophosphamide Rituximab or Bendamustine and Rituximab

2015 Blood
Show All
- Source
- Cite
- Save
Citations (0)
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape.

2015 Oncotarget
Show All
- Source
- Cite
- Save
Citations (20)
Bendamustine and Rituximab Combination Is Safe and Effective As Salvage Regimen in Waldenstrom's Macroglobulinemia

2014 Blood
Show All
- Source
- Cite
- Save
Citations (1)
An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia.

2011 Blood
Show All
- Source
- Cite
- Save
Citations (31)
Safety and Efficacy of Bendamustine with or without Rituximab for the Treatment of Heavily Pretreated CLL and Lymphoma Patients. A Multicenter Retrospective Study.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (4)
Estrogens and Progesterone Promote Persistent CCND1 Gene Activation during G1 by Inducing Transcriptional Derepression via c-Jun/c-Fos/Estrogen Receptor (Progesterone Receptor) Complex Assembly to a Distal Regulatory Element and Recruitment of Cyclin D1 to Its Own Gene Promoter

2004 Molecular and Cellular Biology
Show All
- Source
- Cite
- Save
Citations (145)
Transcriptional Control of Cell Cycle Progression by Estrogenic Hormones: Regulation of Human Cyclin D1 Gene Promoter Activity by Estrogen Receptor-a

2001
Show All
- Source
- Cite
- Save
Citations (2)
Inhibition of human breast cancer cell growth by blockade of the mevalonate-protein prenylation pathway is not prevented by overexpression of cyclin D1

2001 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (4)